Dr. WANG Shujie (王淑杰)

?
Filters
Filters

Reset

to
1 - 3 out of 3Page size: 20

Research Output

  1. 2025
  2. Accepted/In press/Filed

    Activation of parasympathetic pathway from DMV to the thymus inhibits tumor progression

    HE, J. (Inventor), WANG, S. (Inventor), ZHENG, X. (Inventor) & MENG, J. (Inventor), 7 Mar 2025, (Accepted/In press/Filed) Priority No. 63/768,257

    Research output: Patents, Agreements and Assignments › RGC 51 - Patents (CityUHK)

    Check@CityULib
  3. Accepted/In press/Filed

    Cholecystokinin B receptor (CCKBR) antagonist (YF476) inhibits tumor progression

    HE, J. (Inventor), WANG, S. (Inventor), ZHENG, X. (Inventor) & MENG, J. (Inventor), 7 Mar 2025, (Accepted/In press/Filed) Priority No. 63/768,339

    Research output: Patents, Agreements and Assignments › RGC 51 - Patents (CityUHK)

    Check@CityULib
  4. 2023
  5. Published

    Cholecystokinin B receptor antagonists for the treatment of depression via blocking long-term potentiation in the basolateral amygdala

    Zhang, X., Asim, M., Fang, W., Hossain, M. M., Wang, H., Kim, K. & Feng, H. & 4 others, Wang, S., Gao, Q., Lai, Y. & He, J., Aug 2023, In: Molecular Psychiatry. 28, 8, p. 3459–3474

    Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

    Scopus citations: 12
    Check@CityULib